William Pao: Celebrating a Landmark Breakthrough in Hemophilia Care
William Pao, Adjunct Professor of Pharmacology and Medicine at Joan and Sanford I. Weill Medical College of Cornell University, Chief Executive Officer at Revelio Therapeutics, shared a post on LinkedIn about a recent article by him, published in PNAS, adding:
“Please join me in wishing congratulations to Kunihiro Hattori, Takehisa Kitazawa and Tomoyuki Igawa from Chugai Pharmaceutical Co., Ltd.!
They have just been awarded by The Albert and Mary Lasker Foundation the 2026 Lasker-Debakey Clinical Medical Research Award for invention of a bispecific antibody that joins blood clotting Factors IXa (FIXa) and X (FX), restoring deficient Factor VIII (FVIII) activity in patients with hemophilia A and preventing severe bleeding in this hereditary disorder.
Over the span of 10 years, starting in 2000, Hattori – a molecular and hematology biologist, Kitazawa – a hematology biologist and translational researcher, and Igawa – a biochemist and protein engineer, conceived, designed and created emicizumab, a novel FVIII-mimetic.
Their collective research efforts demonstrate how imagination, determination and multidisciplinary scientific research come together to improve patients’ lives.
Their journey highlights what it takes to make true first-in-class breakthrough medicines for patients.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease